Physician profile
Randy C Luzania
NPI 1558356543
$2,348.63
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,928 · 2020: $408 · 2021: $12.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $402.62 | 2019-2020 | |
| Pfizer INC. | $278.39 | 2019-2021 | |
| Novo Nordisk INC | $246.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $199.69 | 2019-2020 | |
| Lilly USA, LLC | $170.94 | 2019 | |
| Merck Sharp & Dohme LLC | $158.38 | 2019-2020 | |
| Amarin Pharma, INC. | $153.63 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $110.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.42 | 2019-2020 | |
| Antares Pharma, INC. | $104.05 | 2019-2020 | |
| Abbvie INC. | $98.79 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $47.37 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $38.87 | 2019-2020 | |
| Shire North American Group INC | $36.42 | 2019 | |
| Glaxosmithkline, LLC. | $33.73 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $28.76 | 2019 | |
| Eisai INC. | $28.59 | 2019 | |
| Allergan, INC. | $24.90 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.61 | 2020 | |
| Hologic Sales and Service, LLC | $15.99 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.66 | 2019 | |
| Alfasigma USA, INC. | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Luzania listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.